Keytruda tops $7B quarterly sales for the first time
Merck’s Keytruda has a new line on its long list of accomplishments: topping $7 billion in quarterly sales for the first time.
On Tuesday, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
